Letter by Murry et al regarding article, embryonic stem cell-derived cardiac myocytes are not ready for human trials

Circulation Research

Volumn 115, Issue 10, 2014, Pages e28-e29

  Murry, Charles E ^a   Chong, James J H ^b,c,d   Laflamme, Michael A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; EMBRYONIC STEM CELL; HEART FUNCTION; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; LETTER; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; ANIMAL; CARDIAC MUSCLE CELL; CYTOLOGY; HEART; MALE; MYOCARDIAL INFARCTION; PATHOLOGY; REGENERATION;

ANIMALS; EMBRYONIC STEM CELLS; HEART; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; REGENERATION;

EID: 84924845270     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.305042     Document Type: Letter

References (12)

1. Chong JJ, Yang X, Don CW, et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. 2014;510:273-277.
2. Anderson ME, Goldhaber J, Houser SR, Puceat M, Sussman MA. Embryonic stem cell-derived cardiac myocytes are not ready for human trials. Circ Res. 2014;115:335-338.
3. Ueno S, Weidinger G, Osugi T, Kohn AD, Golob JL, Pabon L, Reinecke H, Moon RT, Murry CE. Biphasic role for Wnt/beta-catenin signaling in cardiac specifcation in zebrafsh and embryonic stem cells. Proc Natl Acad Sci USA. 2007;104:9685-9690.
4. Lafamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007;25:1015-1024.
5. Fernandes S, Naumova AV, Zhu WZ, Lafamme MA, Gold J, Murry CE. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol. 2010;49:941-949.
6. Shiba Y, Fernandes S, Zhu WZ, et al. Human ES-cell-derived cardio-myocytes electrically couple and suppress arrhythmias in injured hearts. Nature. 2012;489:322-325.
7. Riolobos L, Hirata RK, Turtle CJ, Wang PR, Gornalusse GG, Zavajlevski M, Riddell SR, Russell DW. HLA engineering of human pluripotent stem cells. Mol Ther. 2013;21:1232-1241.
8. Paige SL, Thomas S, Stoick-Cooper CL, Wang H, Maves L, Sandstrom R, Pabon L, Reinecke H, Pratt G, Keller G, Moon RT, Stamatoyannopoulos J, Murry CE. A temporal chromatin signature in human embryonic stem cells identifes regulators of cardiac development. Cell. 2012;151:221-232.
9. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, Ellis J, Keller G. Stage-specifc optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripo-tent stem cell lines. Cell Stem Cell. 2011;8:228-240.
10. Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, Hsiao C, Kamp TJ, Palecek SP. Directed cardiomyocyte differentiation from human plu-ripotent stem cells by modulating Wnt/β-catenin signaling under fully de-fned conditions. Nat Protoc. 2013;8:162-175.
11. Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, Lan F, Diecke S, Huber B, Mordwinkin NM, Plews JR, Abilez OJ, Cui B, Gold JD, Wu JC. Chemically defned generation of human cardiomyocytes. Nat Methods. 2014;11:855-860.
12. Zhang J, Klos M, Wilson GF, et al. Extracellular matrix promotes highly effcient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res. 2012;111:1125-1136.